TIAA CREF Investment Management’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $290K | Buy |
16,783
+2,436
| +17% | +$42.1K | ﹤0.01% | 2787 |
|
2018
Q4 | $253K | Hold |
14,347
| – | – | ﹤0.01% | 2822 |
|
2018
Q3 | $260K | Sell |
14,347
-3,565
| -20% | -$64.6K | ﹤0.01% | 2924 |
|
2018
Q2 | $350K | Buy |
+17,912
| New | +$350K | ﹤0.01% | 2909 |
|
2017
Q2 | – | Sell |
-32,995
| Closed | -$389K | – | 3208 |
|
2017
Q1 | $389K | Sell |
32,995
-1,194
| -3% | -$14.1K | ﹤0.01% | 2878 |
|
2016
Q4 | $448K | Sell |
34,189
-946
| -3% | -$12.4K | ﹤0.01% | 2884 |
|
2016
Q3 | $509 | Hold |
35,135
| – | – | ﹤0.01% | 2839 |
|
2016
Q2 | $421K | Buy |
35,135
+2,922
| +9% | +$35K | ﹤0.01% | 2937 |
|
2016
Q1 | $601K | Hold |
32,213
| – | – | ﹤0.01% | 2730 |
|
2015
Q4 | $692K | Buy |
32,213
+1,721
| +6% | +$37K | ﹤0.01% | 2779 |
|
2015
Q3 | $516K | Buy |
30,492
+11,455
| +60% | +$194K | ﹤0.01% | 2877 |
|
2015
Q2 | $714K | Buy |
+19,037
| New | +$714K | ﹤0.01% | 2852 |
|